US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Triamcinolone Acetonide Cream USP

Reason CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

Padagis US LLC NDC 45802-064-36 D-1497-2022
Class II · Moderate risk Terminated

Proton Armor

Reason Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.

Ultra Chem Labs Corp NDC 79208-001-50 D-0017-2023
Class II · Moderate risk Terminated

Proton Armor

Reason Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.

Ultra Chem Labs Corp NDC 79208-001-50 D-0016-2023
Class II · Moderate risk Terminated

Ketorolac Tromethamine Injection

Reason cGMP Deviations: deviations leading to potential cross-contamination.

Nephron Sc Inc NDC 0487-6232-01 D-1354-2022
Class II · Moderate risk Terminated

PF-Labetalol HCl Injection

Reason CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Nephron Sterile Compounding Center LLC NDC 69374-946-34 D-1347-2022
Class II · Moderate risk Terminated

PF-0.125% Bupivacaine HCl Injection

Reason CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Nephron Sterile Compounding Center LLC NDC 69374-970-05 D-1346-2022
Class II · Moderate risk Terminated

Trisodium Citrate 0.5% Solution

Reason CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Nephron Sterile Compounding Center LLC NDC 69374-910-04 D-1345-2022
Class II · Moderate risk Terminated

PF-Neostigmine Methylsulfate Injection

Reason CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Nephron Sterile Compounding Center LLC NDC 69374-932-33 D-1344-2022
Class II · Moderate risk Terminated

Maxim Instant Foam Hand Sanitizer

Reason CGMP Deviations: Product manufactured using expired active ingredient, Benzalkonium chloride.

Midlab Incorporated D-1463-2022
Class II · Moderate risk Terminated

Acetaminophen Injection

Reason Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment.

Baxter Healthcare Corporation NDC 36000-306-60 D-1348-2022
Class II · Moderate risk Terminated

Difluprednate Ophthalmic Emulsion 0.05%

Reason Lack of Assurance of Sterility: Complaints received of defective container closure.

Cipla NDC 69097-341-35 D-1328-2022
Class II · Moderate risk Terminated

Rifampin Capsules

Reason CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.

Lupin Pharmaceuticals Inc. D-1343-2022
Class II · Moderate risk Terminated

Matzim LA

Reason Failed Dissolution Specifications: below specification limits for dissolution.

Teva Pharmaceuticals USA Inc NDC 58544-692-30 D-1303-2022
Class II · Moderate risk Terminated

Matzim LA

Reason Failed Dissolution Specifications: below specification limits for dissolution.

Teva Pharmaceuticals USA Inc NDC 52544-691-30 D-1302-2022
Class II · Moderate risk Terminated

Prednisone Tablets USP

Reason Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

Strides Pharma Inc. NDC 64380-785-06 D-1330-2022
Class II · Moderate risk Terminated

Irbesartan Tablets

Reason Failed Dissolution Specifications

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-447-90 D-1294-2022
Class II · Moderate risk Terminated

Irbesartan Tablets

Reason Failed dissolution specifications.

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-448-90 D-1293-2022